The COVID-19 Long Haul Foundation

Treatment, Referral & Educational Support for COVID-19 Illnesses & Vaccine Injury

Post-Acute COVID-19 Joint Pain and New Onset of Rheumatic Musculoskeletal Diseases: A Systematic Review

Jacopo Ciaffi 1,*, Elena Vanni 1, Luana Mancarella 1, Veronica Brusi 1,et. al, PMCID: PMC10252492  PMID: 37296705 Abstract As the number of reports of post-acute COVID-19 musculoskeletal manifestations is rapidly rising, it is important to summarize the current available […]

Fatigue and symptom-based clusters in post COVID-19 patients: a multicenter, prospective, observational cohort study

Merel E. B. Cornelissen, Lizan D. Bloemsma, , et. al., Journal of Translational Medicine volume 22, Article number: 191 (2024) Abstract Background In the Netherlands, the prevalence of post COVID-19 condition is estimated at 12.7% at 90–150 days […]

Resonant breathing improves self-reported symptoms and wellbeing in people with Long COVID

Jessica Polizzi, Jenna Tosto-Mancuso, Laura Tabacof, Jamie Wood, David Putrino Introduction: Long COVID involves debilitating symptoms, many of which mirror those observed with dysautonomia, and care must be taken with rehabilitation […]

New-onset chronic musculoskeletal pain following COVID-19 infection fulfil the Fibromyalgia clinical syndrome criteria

Omar Khoja,  Matthew Mulvey, Sarah Astill,  et. al. ,doi: https://doi.org/10.1101/2024.07.10.24310234 ABSTRACT Background New-onset chronic musculoskeletal (MSK) pain (> 3 months duration) is one of the commonest persistent symptoms of Post-COVID syndrome (PCS). There is emerging evidence that the […]

Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study.

O’Kelly B 1,2, Vidal L 2, McHugh T 2, et. al. Brain, Behavior, & Immunity – Health, 03 Jul 2022, 24:100485, https://doi.org/10.1016/j.bbih.2022.100485 PMID: 35814187 PMCID: PMC9250701 Abstract  Background Up to 37.7% of patients experience symptoms beyond 12 weeks after […]